Trials / Completed
CompletedNCT01750242
Retrospective, Non-significant Risk, Deep Brain Stimulation (DBS) Care Management Software Feasibility Study
OPTIVISE Map Concordance Study in DBS for Parkinson's Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- MedtronicNeuro · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate DBS device settings and match with the features of the DBS care management software.
Detailed description
This is a study done on Parkinson disease subjects who have received the DBS system implanted in their subthalamic nucleus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Medtronic DBS system | Advanced Parkinson's disease patients implanted with the Medtronic Deep Brain Stimulation (DBS) system. |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2013-05-01
- Completion
- 2013-08-01
- First posted
- 2012-12-17
- Last updated
- 2024-06-03
- Results posted
- 2014-09-17
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01750242. Inclusion in this directory is not an endorsement.